申请人:PLIVA farmaceutska, kemijska, prehrambena i kozmeticka industrija,
公开号:US05635529A1
公开(公告)日:1997-06-03
Novel O-substituted or O-unsubstituted 6-sulfonamido-1,3-dioxepane-5-ols having hypoglycemic activity are obtained from 6-amino-1,3-dioxepane-5-ol, tetrahydro-6H-[1,3]-dioxepino[5,6-d]oxazole, 5,6-epoxy-1,3-dioxepane or N-sulfonyl-tetrahydro-1H,4H-[1,3]-dioxepino[5,6-b]azirine as starting materials.
从6-氨基-1,3-二氧杂环庚烷-5-醇、四氢-6H-[1,3]-二氧杂环[5,6-d]噁唑、5,6-环氧-1,3-二氧杂环庚烷或N-磺酰基-四氢-1H,4H-[1,3]-二氧杂环[5,6-b]氮杂环丙烯作为起始原料,可以得到具有降糖活性的新型O-取代或O-未取代的6-磺酰胺基-1,3-二氧杂环庚烷-5-醇。